Search

Roy R. Teller

Examiner (ID: 12058, Phone: (571)272-0971 , Office: P/1675 )

Most Active Art Unit
1654
Art Unit(s)
1654, 1675, 1653
Total Applications
671
Issued Applications
374
Pending Applications
45
Abandoned Applications
251

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5296001 [patent_doc_number] => 20090010927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells' [patent_app_type] => utility [patent_app_number] => 11/789239 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 80575 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010927.pdf [firstpage_image] =>[orig_patent_app_number] => 11789239 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/789239
Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells Apr 23, 2007 Issued
Array ( [id] => 4287 [patent_doc_number] => 07816326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-19 [patent_title] => 'Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease' [patent_app_type] => utility [patent_app_number] => 11/733479 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9455 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/816/07816326.pdf [firstpage_image] =>[orig_patent_app_number] => 11733479 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/733479
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease Apr 9, 2007 Issued
Array ( [id] => 5558009 [patent_doc_number] => 20090269586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Multimicrolamellar Collagen Membranes' [patent_app_type] => utility [patent_app_number] => 12/296018 [patent_app_country] => US [patent_app_date] => 2007-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14131 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269586.pdf [firstpage_image] =>[orig_patent_app_number] => 12296018 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/296018
Multimicrolamellar Collagen Membranes Apr 2, 2007 Abandoned
Array ( [id] => 4734366 [patent_doc_number] => 20080051346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Compounds and methods for modulating cell-adhesion mediated drug resistance' [patent_app_type] => utility [patent_app_number] => 11/731947 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 16787 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051346.pdf [firstpage_image] =>[orig_patent_app_number] => 11731947 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/731947
Compounds and methods for modulating cell-adhesion mediated drug resistance Mar 29, 2007 Abandoned
Array ( [id] => 8435546 [patent_doc_number] => 08283315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Inhibition of tumour growth' [patent_app_type] => utility [patent_app_number] => 11/726172 [patent_app_country] => US [patent_app_date] => 2007-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 31060 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11726172 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/726172
Inhibition of tumour growth Mar 20, 2007 Issued
Array ( [id] => 4977893 [patent_doc_number] => 20070219126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Class of bioactive glycoprotein' [patent_app_type] => utility [patent_app_number] => 11/711141 [patent_app_country] => US [patent_app_date] => 2007-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10826 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219126.pdf [firstpage_image] =>[orig_patent_app_number] => 11711141 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/711141
Class of bioactive glycoprotein Feb 26, 2007 Abandoned
Array ( [id] => 5091676 [patent_doc_number] => 20070231315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Stabilized preparations of serine endopeptidases, their preparation and use' [patent_app_type] => utility [patent_app_number] => 11/709747 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8776 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231315.pdf [firstpage_image] =>[orig_patent_app_number] => 11709747 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/709747
Stabilized preparations of serine endopeptidases, their preparation and use Feb 22, 2007 Issued
Array ( [id] => 162543 [patent_doc_number] => 07671025 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Neurotensin receptor agonists and opioid receptor agonists' [patent_app_type] => utility [patent_app_number] => 11/709991 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8735 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/671/07671025.pdf [firstpage_image] =>[orig_patent_app_number] => 11709991 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/709991
Neurotensin receptor agonists and opioid receptor agonists Feb 22, 2007 Issued
Array ( [id] => 6000534 [patent_doc_number] => 20110117017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'PEPTIDES WITH PROPERTIES OF AN ALLOSTERIC ANTAGONIST SELECTIVE FOR THE ALPHA 1A ADRENERGIC RECEPTOR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/279250 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7028 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117017.pdf [firstpage_image] =>[orig_patent_app_number] => 12279250 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/279250
PEPTIDES WITH PROPERTIES OF AN ALLOSTERIC ANTAGONIST SELECTIVE FOR THE ALPHA 1A ADRENERGIC RECEPTOR AND USES THEREOF Feb 22, 2007 Abandoned
Array ( [id] => 6552686 [patent_doc_number] => 20100233302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'THE USE OF A VEGF BINDING PEPTIDE TO RETARD HAIR GROWTH' [patent_app_type] => utility [patent_app_number] => 12/160475 [patent_app_country] => US [patent_app_date] => 2007-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5010 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233302.pdf [firstpage_image] =>[orig_patent_app_number] => 12160475 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/160475
THE USE OF A VEGF BINDING PEPTIDE TO RETARD HAIR GROWTH Jan 25, 2007 Abandoned
Array ( [id] => 5538817 [patent_doc_number] => 20090220622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'USE OF MIMOSINE OR A DERIVATIVE THEREOF FOR TREATING THE CUTANEOUS EFFECTS OF PSORIASIS AND RELATED SKIN DISORDERS, AND COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING SAME' [patent_app_type] => utility [patent_app_number] => 12/161924 [patent_app_country] => US [patent_app_date] => 2007-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11102 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220622.pdf [firstpage_image] =>[orig_patent_app_number] => 12161924 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/161924
USE OF MIMOSINE OR A DERIVATIVE THEREOF FOR TREATING THE CUTANEOUS EFFECTS OF PSORIASIS AND RELATED SKIN DISORDERS, AND COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING SAME Jan 22, 2007 Abandoned
Array ( [id] => 54042 [patent_doc_number] => 07767649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-03 [patent_title] => 'Amino acid conjugates providing for sustained systemic concentrations of GABA analogues' [patent_app_type] => utility [patent_app_number] => 11/654598 [patent_app_country] => US [patent_app_date] => 2007-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18049 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767649.pdf [firstpage_image] =>[orig_patent_app_number] => 11654598 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/654598
Amino acid conjugates providing for sustained systemic concentrations of GABA analogues Jan 17, 2007 Issued
Array ( [id] => 1077022 [patent_doc_number] => 07615535 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Inhibiting GS-FDH to modulate no bioactivity' [patent_app_type] => utility [patent_app_number] => 11/648406 [patent_app_country] => US [patent_app_date] => 2006-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9493 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615535.pdf [firstpage_image] =>[orig_patent_app_number] => 11648406 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/648406
Inhibiting GS-FDH to modulate no bioactivity Dec 28, 2006 Issued
Array ( [id] => 5005495 [patent_doc_number] => 20070203066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Compositions and methods for inhibiting cellular proliferation' [patent_app_type] => utility [patent_app_number] => 11/636353 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17740 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203066.pdf [firstpage_image] =>[orig_patent_app_number] => 11636353 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/636353
Compositions and methods for inhibiting cellular proliferation Dec 7, 2006 Abandoned
Array ( [id] => 5005495 [patent_doc_number] => 20070203066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Compositions and methods for inhibiting cellular proliferation' [patent_app_type] => utility [patent_app_number] => 11/636353 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17740 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203066.pdf [firstpage_image] =>[orig_patent_app_number] => 11636353 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/636353
Compositions and Methods for Inhibiting Cellular Proliferation Dec 7, 2006 Abandoned
Array ( [id] => 5125547 [patent_doc_number] => 20070237818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Controlled-release formulation of HCV protease inhibitor and methods using the same' [patent_app_type] => utility [patent_app_number] => 11/636701 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 50451 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237818.pdf [firstpage_image] =>[orig_patent_app_number] => 11636701 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/636701
Controlled-release formulation of HCV protease inhibitor and methods using the same Dec 6, 2006 Abandoned
Array ( [id] => 6646090 [patent_doc_number] => 20100228005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Process for the Purification of Macrolide Antibiotics' [patent_app_type] => utility [patent_app_number] => 12/095642 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 984 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20100228005.pdf [firstpage_image] =>[orig_patent_app_number] => 12095642 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/095642
Process for the purification of macrolide antibiotics Dec 6, 2006 Issued
Array ( [id] => 5131552 [patent_doc_number] => 20070207949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Medicaments and methods combining a HCV protease inhibitor and an AKR competitor' [patent_app_type] => utility [patent_app_number] => 11/635470 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 52023 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207949.pdf [firstpage_image] =>[orig_patent_app_number] => 11635470 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/635470
Medicaments and methods combining a HCV protease inhibitor and an AKR competitor Dec 6, 2006 Abandoned
Array ( [id] => 4478123 [patent_doc_number] => 07906617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Polyethylene binding peptides and methods of use' [patent_app_type] => utility [patent_app_number] => 11/607672 [patent_app_country] => US [patent_app_date] => 2006-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 15 [patent_no_of_words] => 17960 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906617.pdf [firstpage_image] =>[orig_patent_app_number] => 11607672 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/607672
Polyethylene binding peptides and methods of use Nov 30, 2006 Issued
Array ( [id] => 4823046 [patent_doc_number] => 20080227717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Potent compstatin analogs' [patent_app_type] => utility [patent_app_number] => 11/605182 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14141 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227717.pdf [firstpage_image] =>[orig_patent_app_number] => 11605182 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/605182
Potent compstatin analogs Nov 27, 2006 Issued
Menu